New protection insurer to enter the market after securing £180m start-up funding

clock • 2 min read

Entrepreneurial start-up company Gryphon Group Holdings Limited, has raised £180m in funding to design and build an 'insurance challenger' that seeks to protect more families in the UK.

The insuretech company will focus initially on life, critical illness and income protection and will announce the insurer's brand name later in the year. It will be harnessing digital and cloud based technologies. The business said that it "will be people-centred not technology-led, putting customer and adviser needs at the heart of its business." Its co-founders are Chief Executive Officer, Daniel Pender, former Executive Director at Prudential and UK Life Chief Financial Officer at Zurich; and Chief Operating Officer, Simon Davis, former Chief Risk Officer at Guardian and Corporate ...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

The COVER Review: Protection growth, the NHS and employee benefits

The COVER Review: Protection growth, the NHS and employee benefits

Week commencing 9 November 2026

COVER
clock 13 November 2026 • 1 min read
Most homeowners want mortgage advisers to discuss redundancy

Most homeowners want mortgage advisers to discuss redundancy

58% expect redundancy risk to increase in the next five years

Jaskeet Briah
clock 05 November 2026 • 2 min read
Protection applicants see rise in disclosure of weight loss treatment: UnderwriteMe

Protection applicants see rise in disclosure of weight loss treatment: UnderwriteMe

Buy-now outcomes "remain strong"

Jaskeet Briah
clock 04 November 2026 • 2 min read